1. Suppression of MMP-9 and FAK expression by pomolic acid via blocking of NF-κB/ERK/mTOR signaling pathways in growth factor-stimulated human breast cancer cells
   Ji-Hyun Park et al, 2016, International Journal of Oncology CrossRef
2. Self-Assembly of a Linear–Dendritic Polymer Containing Cisplatin and Norcantharidin into Raspberry-like Multimicelle Clusters for the Efficient Chemotherapy of Liver Cancer
   Mingli Wei et al, 2023, ACS Applied Materials & Interfaces CrossRef
3. Norcantharidin inhibits Wnt signal pathway via promoter demethylation of WIF-1 in human non-small cell lung cancer
   Junran Xie et al, 2015, Medical Oncology CrossRef
4. Fabrication of epidermal growth factor imprinted and demethylcantharidin loaded dendritic mesoporous silica nanoparticle: An integrated drug vehicle for chemo-/antibody synergistic cancer therapy
   J.Z. Ma et al, 2021, Journal of Drug Delivery Science and Technology CrossRef
5. Norcantharidin induces autophagy-related prostate cancer cell death through Beclin-1 upregulation by miR-129-5p suppression
   Wenjun Xiao et al, 2016, Tumor Biology CrossRef
6. Insight into norcantharidin, a small-molecule synthetic compound with potential multi-target anticancer activities
   Mu-Su Pan et al, 2020, Chinese Medicine CrossRef
7. Gefitinib induces non‑small cell lung cancer H1650 cell apoptosis through downregulating tumor necrosis factor‑related apoptosis‑inducing ligand expression levels
   Hanjie Yi et al, 2018, Oncology Letters CrossRef
8. Helminthes and insects: maladies or therapies
   Nora L. El-Tantawy, 2015, Parasitology Research CrossRef
9. Norcantharidin combined with EGFR-TKIs overcomes HGF-induced resistance to EGFR-TKIs in EGFR mutant lung cancer cells via inhibition of Met/PI3k/Akt pathway
   Hongyan Wu et al, 2015, Cancer Chemotherapy and Pharmacology CrossRef
10. Norcantharidin in cancer therapy – a new approach to overcoming therapeutic resistance: A review
    Beilei Zeng et al, 2024, Medicine CrossRef
11. Norcantharidin induce apoptosis in human nasopharyngeal carcinoma through caspase and mitochondrial pathway
    Andy Wei‐Ge Chen et al, 2018, Environmental Toxicology CrossRef
12. Synthetic genetic array screen identifies PP2A as a therapeutic target in Mad2-overexpressing tumors
    Yang Bian et al, 2014, Proceedings of the National Academy of Sciences CrossRef
13. Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010–2020)
    Jiaqi Xiao et al, 2020, European Journal of Medicinal Chemistry CrossRef
14. Synergistic Antitumor Effect of Genitinib (Iressa®) with Flavonoids from the Scutellaria baicalensis Root on the Non-Small Cell Lung Cells
    Y. Hirata et al, 2017, The Open Plant Science Journal CrossRef
15. Norcantharidin modulates miR-655-regulated SENP6 protein translation to suppresses invasion of glioblastoma cells
    Zhenxing Zhang et al, 2016, Tumor Biology CrossRef
16. Cantharidin impedes the activity of protein serine/threonine phosphatase in Plutella xylostella
    Xi'en Chen et al, 2014, Mol. BioSyst. CrossRef
17. Pharmacogenomics of cantharidin in tumor cells
    Onat Kadioglu et al, 2014, Biochemical Pharmacology CrossRef
18. Norcantharidin modulates the miR-30a/Metadherin/AKT signaling axis to suppress proliferation and metastasis of stromal tumor cells in giant cell tumor of bone
    Feiyan Chen et al, 2018, Biomedicine & Pharmacotherapy CrossRef
19. In vitro and in vivo antitumor effect of gefitinib nanoparticles on human lung cancer
    Xiao Ling Ni et al, 2017, Drug Delivery CrossRef
20. Anticancer Potentials of Hard Lump-Resolving and Swelling-Reducing Herbs
    Xu Jun, 2016, Cancer Inhibitors from Chinese Natural Medicines CrossRef
21. Norcantharidin blocks Wnt/β-catenin signaling via promoter demethylation of WIF-1 in glioma
    DAJIANG XIE et al, 2016, Oncology Reports CrossRef